Close Menu

Lung Cancer

News and reporting on lung cancer.

The merger will give Biosystems International access to MicroBioChips' nanoarray technology and its sales and marketing resources, which are expected to help the company establish new relationships with university-based proteomics laboratories and pharma and biotech firms.

The agreement with NEC, which has purchased an equity stake in the company, is part of its plan to expand beyond its traditional focus on biomarker discovery and diagnostics development to become a "health information company" that can "provide actionable medical information to patients, physicians, and researchers," said an official.

The donation will fund research at the Institute for Personalized Cancer Therapy and the Center for Targeted Therapy into more effective drug treatments, including investigations into protein pathway-directed therapies, said an official.

Results from the 94-subject study suggest that the test could be useful in screening high-risk patients for ovarian cancer and possibly even as a screening diagnostic for the general population, a Georgia Tech researcher said.

In a study, Merck scientists identified 71 phosphoproteins that could be useful biomarkers for predicting the efficacy of drugs targeting a cancer-linked signaling pathway.

The company next year plans to launch a 1,000-patient verification trial for its lung cancer protein biomarker panel, with trials for its Alzheimer's disease panel likely to follow, said an official.

The center will focus on developing biomarker panels for measuring patient response to drug treatments for lung cancer, chronic obstructive pulmonary disease, and cardiovascular disease, said one of its founders.

The company will be using the funds to develop and test a prototype of the diagnostic, which it hopes to bring to market sometime in 2011, said a company official.

Roche presents data from HPV Dx trial; Epigenomics launches Epi proLung BL Reflex Assay in Europe.

A company official said that VeriStrat sales are growing at a double-digit pace and that Biodesix is also looking to apply the test to diseases beyond lung cancer.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.